Ian King: Cryptocurrency expert and Entrepreneur
Ian King grew up on New Jersey shore, worked as an ocean lifeguard during summer vacations. He was made the captain of the busiest beach in Belmar at the age of 19. He received a Bachelor of Science degree in psychology. He had a passion for trading while in school that prompted him to start trading in dot-com stocks from his dorm room. Because of his interest in trading, he went on to an internship program at Merrill Lynch. He acquired necessary skill and experience through rescuing people as a lifeguard which he applied in his entrepreneur journey in trading.
Ian King was a former hedge fund manager and now an expert in cryptocurrency trading. He has many years of knowledge in analyzing and trading in the financial market. He is a senior contributing editor at the Banyan Hill publishing and first established crypto investing multimedia product for Investopedia.
Cryptocurrencies are a vital change in the way people can exchange something of value built on trust. He believes the economies do well in societies where people trust each other.
A unicorn in the financial industry is a startup project or venture that can claim a $1 billion in the estimate and it can be used as a real rarity. Many companies all over the world have been labeled as unicorns namely Pinterest, Dropbox, Uber, and Airbnb. These unicorn companies have a combined investment of two hundred billion and a $967 billion market evaluation. This amounts to a high percentage return of 4oo in about two years.
Investors presently trust that they will be where they need to be to get in at the start of a new big thing or venture. This condition has created a new startup unicorn called cryptocorn. There are 41 blockchain projects that were estimated at over $1 billion however, bitcoin was the only one that could be a verifiable Cryptocorn.
Ian King is considered a cryptocurrency expert because of his expertise in the financial and trading market for over two decades. As a cryptocurrency trader, he has an impressive knowledge of the market. He is one of the leading contributors in the world of cryptocurrencies. He has designed a program to help educate people about cryptocurrencies like ripple, monero, bitcoin, and litecoin to mention few.
Ian King believes that the distribution of investment among new crypto asset undertakings is just the beginning, as new bitcoin millionaires invest back into their crypto wealth and new entrepreneurs look to exploit the current rush of Investment.
For more information visit website https://www.crunchbase.com/person/ian-king-4924
Matt Badiali is a scientist, researcher, and investment guru. He attended Penn State University for a B.S in Earth Science and later attended Florida Atlantic University for an M.S in Geology. Additionally, Mr. Badiali was busy working for his Ph.D. at the University of North Carolina for five years, when a friend, a Ph.D. holder in finance, drifted his attention from science to finance.
This friend who he had known for a short while, was a financial expert and was planning to venture into major natural resources investments. This being a new field to him, he understood that he required a geologist in his team, for him to make exceptional returns. Realizing that Matt was very knowledgeable in the field of science and geology, he approached him (Matt) for help in crafting an appealing investment advice, in which he obliged.
This required Matt to tour the world and to particular companies, so as to ensure the information they had given in writing was exactly what was on site. Matt was to make assessments to gold mines’ samples, examine the operations of oil wells, as well as make an analysis on the on-site field maps, which he did.
Matt having seen his dad struggle with investment, he wanted to make it easier for people to make fruitful investments through a well-devised plan, rather than making loses. Through his expertise in the industries of mining, agriculture, and energy, Matt has helped lots of investors in their investments making double or even triple profit.
Matt believes that for one to make a safe investment from natural resources, one needs to have performed the firsthand research by personally visiting the site. He also prefers meeting the clients personally, through his “boots on the ground” approach. This has made him travel to different places around the globe. Learn more on seekingalpha.com for more info.
In 2017, Matt launched his newsletter with Banyan Hill Publishingcalled Real Wealth Strategist, which has secured a lot of eager readers for his stock recommendations. His advice is based on his personal experience in the field, which he has garnered through his geological transverse to places like Singapore, Peru, Iran, Papua New Guinea, Turkey, Switzerland, Hong Kong and others. This publication gives advice on investing in metals, oil, construction materials, and agriculture.
Prior to becoming a senior editor in Banyan Hill, Matt was working in a drilling company as a geologist and a consultant in various companies. He has also been a lecturer in the University of California and Duke University. To Matt Badiali, this has been an interesting journey of researching, investing, training, traveling, and writing. Read this link:https://forexvestor.com/real-wealth-strategist-review
We’ve had nearly four years of low gasoline prices. However, we’re paying more for gasoline now, on a relative basis, than we did back in 2008.
— Matt Badiali (@Matt_B_Guru) February 9, 2018
Doctor Jeanmarie Guenot is the President and Chief Executive Officer of Amphivena Therapeutics Incorporated established in July 2013. Guenot has spent over 20 years in the pharmaceutical and biotechnology industry. In the past, she has been involved in all aspects of cancer research with multiple public and private companies including research and development, corporate and commercial development, business development, project and alliance management, and venture capital. Media outlets that have highlighted a few of Guenot’s accomplishments include Market Wired, Yahoo, Biospace.com, and Reuters.
Doctor Guenot started with Atlas Venture managing venture capital investments, and worked as a scientist with preclinical research and development at Hoffman LaRoache where drugs were developed to assist in eliminating metabolic diseases. Prior to her move to Amphivena Therapeutics, Guenot built and ran SKS Ocular which is an ophthalmic incubator company focusing on dry AMD, sustained release ocular drug delivery technologies for glaucoma, macular degeneration and ocular inflammation. Today, Amphivena Therapeutics develops cancer immunotherapies.
A recent accomplish includes the Food and Drug Administration (FDA) accepting an investigational new drug application for AMV564 which is an Amphivena Therapeutics proprietary T-cell redirecting bispecific CD33/CD3 antibody that helps recruit T-cells to rid of cancer cells. By doing so, doctors will now have at their disposal a therapeutic option for AML patients. Guenot and Amphivena Therapeutics look to stop blood cancers with therapies that use the patient’s immune system to destroy the tumor cells.
Amphivena Therapeutics has joined forces with multiple alliances and together is using their experience and resources in the industry to focus on how best to come up with therapy options for patients. Statistically, there is an expectation that over 19 million people will be diagnosed with cancer by the year 2024. This amounts to 39.6% of the world’s population of men and women. The work that Doctor Jeanmarie Guenot and her team members are completing will slow down cancer in the short term and hopefully rid of the disease altogether in the future.
Read more on her website here: http://jeanmarieguenot.com/